TY - JOUR
T1 - Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression
AU - Illi, Julie
AU - Miaskowski, Christine
AU - Cooper, Bruce
AU - Levine, Jon D.
AU - Dunn, Laura
AU - West, Claudia
AU - Dodd, Marylin
AU - Dhruva, Anand
AU - Paul, Steven M.
AU - Baggott, Christina
AU - Cataldo, Janine
AU - Langford, Dale
AU - Schmidt, Brian
AU - Aouizerat, Bradley E.
N1 - Funding Information:
This research was supported by a Grant from the National Institute of Nursing Research ( NR04835 ) and partially supported by a UCSF Academic Senate Grant to Drs. Dunn and Aouizerat. Dr. Aouizerat was funded through the National Institutes of Health (NIH) Roadmap for Medical Research Grant ( KL2 RR624130 ). Dr. Miaskowski is funded by the American Cancer Society as a Clinical Research Professor. Dr. Dhruva is funded through NIH Mentored Patient-Oriented Research Career Development Award ( K23 AT005340 ).
PY - 2012/6
Y1 - 2012/6
N2 - Because multiple symptoms associated with " sickness behavior" have a negative impact on functional status and quality of life, increased information on the mechanisms that underlie inter-individual variability in this symptom experience is needed. The purposes of this study were to determine: if distinct classes of individuals could be identified based on their experience with pain, fatigue, sleep disturbance, and depression; if these classes differed on demographic and clinical characteristics; and if variations in pro- and anti- inflammatory cytokine genes were associated with latent class membership.Self-report measures of pain, fatigue, sleep disturbance, and depression were completed by 168 oncology outpatients and 85 family caregivers (FCs). Using latent class profile analysis (LCPA), three relatively distinct classes were identified: those who reported low depression and low pain (83%), those who reported high depression and low pain (4.7%), and those who reported high levels of all four symptoms (12.3%). The minor allele of IL4 rs2243248 was associated with membership in the " All high" class along with younger age, being White, being a patient (versus a FC), having a lower functional status score, and having a higher number of comorbid conditions.Findings suggest that LPCA can be used to differentiate distinct phenotypes based on a symptom cluster associated with sickness behavior. Identification of distinct phenotypes provides new evidence for the role of IL4 in the modulation of a sickness behavior symptom cluster in oncology patients and their FCs.
AB - Because multiple symptoms associated with " sickness behavior" have a negative impact on functional status and quality of life, increased information on the mechanisms that underlie inter-individual variability in this symptom experience is needed. The purposes of this study were to determine: if distinct classes of individuals could be identified based on their experience with pain, fatigue, sleep disturbance, and depression; if these classes differed on demographic and clinical characteristics; and if variations in pro- and anti- inflammatory cytokine genes were associated with latent class membership.Self-report measures of pain, fatigue, sleep disturbance, and depression were completed by 168 oncology outpatients and 85 family caregivers (FCs). Using latent class profile analysis (LCPA), three relatively distinct classes were identified: those who reported low depression and low pain (83%), those who reported high depression and low pain (4.7%), and those who reported high levels of all four symptoms (12.3%). The minor allele of IL4 rs2243248 was associated with membership in the " All high" class along with younger age, being White, being a patient (versus a FC), having a lower functional status score, and having a higher number of comorbid conditions.Findings suggest that LPCA can be used to differentiate distinct phenotypes based on a symptom cluster associated with sickness behavior. Identification of distinct phenotypes provides new evidence for the role of IL4 in the modulation of a sickness behavior symptom cluster in oncology patients and their FCs.
KW - Cytokines
KW - Depression
KW - Fatigue
KW - Pain
KW - Sleep disturbance
UR - http://www.scopus.com/inward/record.url?scp=84860327799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860327799&partnerID=8YFLogxK
U2 - 10.1016/j.cyto.2012.02.015
DO - 10.1016/j.cyto.2012.02.015
M3 - Article
C2 - 22450224
AN - SCOPUS:84860327799
SN - 1043-4666
VL - 58
SP - 437
EP - 447
JO - Cytokine
JF - Cytokine
IS - 3
ER -